157 related articles for article (PubMed ID: 31177149)
1. Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-effects from Induction Chemotherapy in Head and Neck Cancer Patients.
Mikoshiba T; Ozawa H; Saito S; Ikari Y; Nakahara N; Ito F; Watanabe Y; Sekimizu M; Imanishi Y; Ogawa K
Anticancer Res; 2019 Jun; 39(6):3059-3065. PubMed ID: 31177149
[TBL] [Abstract][Full Text] [Related]
2. Platelet-lymphocyte and neutrophil-lymphocyte ratios: Predictive factors of response and toxicity for docetaxel-combined induction chemotherapy in advanced head and neck cancers.
Liu YH; Lin YS
J Chin Med Assoc; 2019 Nov; 82(11):849-855. PubMed ID: 31453862
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.
Huang CE; Lu CH; Chen PT; Chan CH; Chen WC; Wang WH; Wu JY; Kuan FC; Lee KD; Chen CC
J Clin Pharm Ther; 2012 Jun; 37(3):342-7. PubMed ID: 21950487
[TBL] [Abstract][Full Text] [Related]
4. Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines.
Wang TY; Chen WM; Yang LY; Chen CY; Chou WC; Chen YY; Chen CC; Lee KD; Lu CH
Support Care Cancer; 2016 Nov; 24(11):4697-703. PubMed ID: 27329415
[TBL] [Abstract][Full Text] [Related]
5. [Toxicity of docetaxel, platine, 5-fluorouracil-based induction chemotherapy for locally advanced head and neck cancer: The importance of nutritional status].
Bernadach M; Lapeyre M; Dillies AF; Miroir J; Moreau J; Kwiatkowski F; Pham-Dang N; Saroul N; Durando X; Biau J
Cancer Radiother; 2019 Jul; 23(4):273-280. PubMed ID: 31138520
[TBL] [Abstract][Full Text] [Related]
6. Incidence and predictors of febrile neutropenia during chemotherapy in patients with head and neck cancer.
Takenaka Y; Cho H; Yamamoto M; Nakahara S; Yamamoto Y; Inohara H
Support Care Cancer; 2013 Oct; 21(10):2861-8. PubMed ID: 23748486
[TBL] [Abstract][Full Text] [Related]
7. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.
Lowe NM; Bernstein JM; Mais K; Garcez K; Lee LW; Sykes A; Thomson DJ; Homer JJ; West CM; Slevin NJ
J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650
[TBL] [Abstract][Full Text] [Related]
8. Predictive Factors for Completion of TPF Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer.
Nakano K; Seto A; Sasaki T; Shimbashi W; Fukushima H; Yonekawa H; Mitani H; Takahashi S
Anticancer Res; 2019 Aug; 39(8):4337-4342. PubMed ID: 31366527
[TBL] [Abstract][Full Text] [Related]
9. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
10. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma.
Rassouli A; Saliba J; Castano R; Hier M; Zeitouni AG
Head Neck; 2015 Jan; 37(1):103-10. PubMed ID: 24339165
[TBL] [Abstract][Full Text] [Related]
11. Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab.
Tanoue K; Tamura S; Kusaba H; Shinohara Y; Ito M; Tsuchihashi K; Shirakawa T; Otsuka T; Ohmura H; Isobe T; Ariyama H; Koreishi S; Matsushita Y; Shimokawa H; Tanaka R; Mitsugi K; Akashi K; Baba E
Sci Rep; 2021 Feb; 11(1):2741. PubMed ID: 33531609
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
Ock CY; Keam B; Kim TM; Han DH; Won TB; Lee SH; Hah JH; Kwon TK; Kim DW; Kim DY; Rhee CS; Wu HG; Sung MW; Heo DS
Korean J Intern Med; 2016 May; 31(3):570-8. PubMed ID: 26976150
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
Kim R; Hahn S; Shin J; Ock CY; Kim M; Keam B; Kim TM; Kim DW; Heo DS
Cancer Res Treat; 2016 Jul; 48(3):907-16. PubMed ID: 26582394
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric study.
Yossi S; Linot B; Peyraga G; Breheret R; Laccourreye L; Capitain O
Int J Clin Oncol; 2015 Dec; 20(6):1086-92. PubMed ID: 25931315
[TBL] [Abstract][Full Text] [Related]
15. Towards risk-stratified induction regimens.
Killock D
Nat Rev Clin Oncol; 2019 Apr; 16(4):209. PubMed ID: 30647429
[No Abstract] [Full Text] [Related]
16. A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.
Mesía R; Vázquez S; Grau JJ; García-Sáenz JA; Lozano A; García C; Carles J; Irigoyen A; Mañós M; García-Paredes B; del Barco E; Taberna M; Escobar Y; Cruz JJ;
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):289-96. PubMed ID: 26675064
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer.
Kano S; Homma A; Hatakeyama H; Mizumachi T; Sakashita T; Kakizaki T; Fukuda S
Head Neck; 2017 Feb; 39(2):247-253. PubMed ID: 27617428
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer.
Wang HM; Lin CY; Hsieh CH; Hsu CL; Fan KH; Chang JT; Huang SF; Kang CJ; Liao CT; Ng SH; Yen TC
J Formos Med Assoc; 2017 Mar; 116(3):185-192. PubMed ID: 27133181
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.
Baghi M; Hambek M; May A; Radeloff A; Gstoettner W; Knecht R
Anticancer Res; 2006; 26(1B):559-63. PubMed ID: 16739320
[TBL] [Abstract][Full Text] [Related]
20. [Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
Chilimoniuk M; Olszewska E; Maksimowicz T
Pol Merkur Lekarski; 2010 Dec; 29(174):357-60. PubMed ID: 21298984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
